The ETF manages assets at the frontier of innovation, and has accomplished a 52% return year-to-date1. WHEATON, Ill., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Innovator Capital Management, LLC ( Innovator) ...
Instead of requiring personalized gene edits for each patient, the new approach could create a standardized method to use for many diseases. By Pam Belluck and Carl Zimmer Gene-editing therapies offer ...
"Our strategy can become a new design principle for researchers who need their engineered cells to work consistently." Images taken via microscope from the study show bright, glowing clusters of ...
Non-viral, DSB-free integration: ABBIE employs a dCas9-integrase fusion to guide targeted, donor-DNA integration while avoiding double-strand breaks and viral delivery. SOHM is a biopharmaceutical ...
No audio available for this content. BDStar Navigation Co. Ltd., a provider of positioning technology solutions, has announced its chip-coud integration strategy and introduced intelligent location ...
Green procurement and tariff resilience: Strategies from Canadian auto suppliers for U.S. automakers
NextGen Supply Chain Conference returns to Nashville in 2026 with focus on innovation, talent, and transformation The 2026 NextGen Supply Chain Conference returns to Nashville with a practitioner-led ...
Guillaume Andrey, UNIGE I've been interested in the genetic mechanisms of development since the beginning of my career.
In our work with organizations worldwide, one of the first questions Oliver Wight Business Advisors ask their client’s employees is, “What is your company’s strategy for the business?” Very often, ...
Gene editing in plants remains challenging, with the traditional non-homologous end-joining (cNHEJ) repair pathway often hindering precision. In this study, researchers advanced CRISPR-Cas-based gene ...
In primary care clinics, implementing integrated strategies involving routine screening, assessment of symptoms, and provision of relevant care improved the rates of screening, diagnosis, and ...
Munster says Apple's strength in hardware and demand for the iPhone 17 could do enough to offset expectations for AI. "Over the past year, Apple may have stumbled on AI, but they continue to lead when ...
Regarding market potential, I see it following an exponential curve, with forecasts indicating that by 2030, gene therapies and genetic corrections will become more widely available, potentially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback